NUTI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 414
EU - Europa 373
AS - Asia 95
OC - Oceania 1
SA - Sud America 1
Totale 884
Nazione #
US - Stati Uniti d'America 411
UA - Ucraina 94
IE - Irlanda 87
IT - Italia 51
SE - Svezia 43
HK - Hong Kong 36
VN - Vietnam 29
FI - Finlandia 27
DE - Germania 26
RU - Federazione Russa 20
CN - Cina 17
GB - Regno Unito 7
TR - Turchia 7
BE - Belgio 5
FR - Francia 5
CH - Svizzera 3
MX - Messico 3
PL - Polonia 3
AT - Austria 2
LB - Libano 2
SG - Singapore 2
BR - Brasile 1
KR - Corea 1
NZ - Nuova Zelanda 1
UZ - Uzbekistan 1
Totale 884
Città #
Dublin 87
Chandler 68
San Mateo 57
Jacksonville 53
Hong Kong 36
Dong Ket 29
Medford 27
Princeton 25
Altamura 21
Perugia 21
Ann Arbor 20
Lawrence 15
Andover 13
Beijing 13
Wilmington 13
Boardman 8
Izmir 7
Woodbridge 7
Ashburn 6
Des Moines 6
Brussels 5
Frankfurt Am Main 4
Saint Petersburg 4
Norwalk 3
Redwood City 3
Chicago 2
Helsinki 2
New York 2
Piemonte 2
San Paolo di Civitate 2
Auburn Hills 1
Auckland 1
Changsha 1
Dallas 1
Dearborn 1
Hangzhou 1
Hanover 1
Mcallen 1
Moscow 1
Nanjing 1
Nottingham 1
Overland Park 1
Seoul 1
Simi Valley 1
Spoleto 1
Tappahannock 1
Totale 577
Nome #
Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5. 70
Adamantyl-substituted retinoid-derived molecules that intercact with the orphan nuclear receptor small heterodimer partner:effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity 67
Side chain modified HDCA derivatives: synthesis, CMC determination and molecular modelling studies. 61
Avicholic acid: a lead compound from birds on the route to potent TGR5 modulators 59
Ligand Binding and Functional Selectivity ofl-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR) 59
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 52
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 47
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 46
Molecular field analysis and quantitative structure-activity studies (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5 receptor. 42
Synthesis, enantiomeric separation and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO), a novel target for cancer therapy 37
High-throughput chromatographic determination of the bile acid critical micellar concentration 33
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 32
Charting the chemical space of target sites: insights into the binding modes of amine and amidine groups. 30
Structural and Conformational Aspects of Molecular Recognition by Indoleamine-2,3-Dioxygenase (IDO), a Novel Target for Cancer Therapy 30
Exploring the effect of PARP-1 flexibility in docking studies 30
Synthesis and Quantitative Structure-Property Relationships of Side Chain-Modified Hyodeoxycholic Acid Derivatives 29
Structural and Conformational Aspects of Molecular Recognition by Indoleamine-2,3-Dioxygenase (IDO), a Novel Target for Cancer Therapy 27
Choline Kinase Active Site Provides Features for Designing Versatile Inhibitors 27
Probing the Binding Site of Bile Acids in TGR5 26
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 26
Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design 24
Exploring Ligand Recognition in the Kynurenine Pathway to Advance the Medicinal Chemistry of Kynurenines 22
Patented TGR5 modulators: a review (2006 - present) 22
Novel method for generating structure-based pharmacophores using energetic analysis. 18
Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1 17
Totale 933
Categoria #
all - tutte 3.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 9 0
2019/202082 1 1 14 1 15 0 13 1 17 4 10 5
2020/2021195 1 16 5 13 62 10 16 1 19 5 16 31
2021/2022169 3 34 3 9 1 0 1 65 2 4 19 28
2022/2023270 26 56 5 13 27 26 0 3 101 0 11 2
2023/202488 8 22 6 0 2 0 26 5 12 1 6 0
Totale 933